NAFLD/MASLD and the gut–liver axis: From pathogenesis to treatment options

NG Vallianou, D Kounatidis, S Psallida… - Metabolites, 2024 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) poses an emerging threat topublic health.
Nonalcoholic steatohepatitis (NASH) is reported to be the most rapidly rising cause of …

Non-alcoholic fatty liver disease and gut microbial dysbiosis-underlying mechanisms and gut microbiota mediated treatment strategies

M Jayachandran, S Qu - Reviews in Endocrine and Metabolic Disorders, 2023 - Springer
Non-alcoholic fatty liver disease (NAFLD) is by far the most prevalent form of liver disease
worldwide. It's also the leading cause of liver-related hospitalizations and deaths …

Metabolic-dysfunction-associated fatty liver disease and gut microbiota: From fatty liver to dysmetabolic syndrome

L Abenavoli, GGM Scarlata, E Scarpellini, L Boccuto… - Medicina, 2023 - mdpi.com
Metabolic-dysfunction-associated fatty liver disease (MAFLD) is the recent nomenclature
designation that associates the condition of non-alcoholic fatty liver disease (NAFLD) with …

Prebiotics and probiotics: Therapeutic tools for nonalcoholic fatty liver disease

A Mijangos-Trejo, N Nuño-Lambarri… - International Journal of …, 2023 - mdpi.com
Alterations in the gut–liver axis and changes in the gut microbiome are among the risk
factors for the pathogenesis of non-alcoholic fatty liver disease (NAFLD). These patients …

Sanguisorba officinalis L. Ameliorates Hepatic Steatosis and Fibrosis by Modulating Oxidative Stress, Fatty Acid Oxidation, and Gut Microbiota in CDAHFD-Induced …

Y Nam, M Kim, S Erdenebileg, KH Cha, DH Ryu… - Nutrients, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver diseases and
encompasses non-alcoholic steatosis, steatohepatitis, and fibrosis. Sanguisorba officinalis …

The potential of short-chain fatty acid epigenetic regulation in chronic low-grade inflammation and obesity

J Kopczyńska, M Kowalczyk - Frontiers in Immunology, 2024 - frontiersin.org
Obesity and chronic low-grade inflammation, often occurring together, significantly
contribute to severe metabolic and inflammatory conditions like type 2 diabetes (T2D) …

[HTML][HTML] Impact of Lactobacillaceae supplementation on the multi-organ axis during MASLD

AA Santos, R Duarte, M Duarte, F Arella, V Marques… - Life Sciences, 2024 - Elsevier
The gut-liver axis plays a pivotal role in maintaining body homeostasis. Disruption of the gut-
liver axis is linked to a multitude of diseases, including metabolic dysfunction-associated …

Assessing the in vivo ameliorative effects of Lactobacillus acidophilus KLDS1.0901 for induced non-alcoholic fatty liver disease treatment

Y Wang, Z Wang, Y Wan, F Jin, X Shi, Z Xing… - Frontiers in …, 2023 - frontiersin.org
Reputed as a significant metabolic disorder, non-alcoholic fatty liver disease (NAFLD) is
characterized by high-fat deposits in the liver and causes substantial economic challenges …

Effect of different levels of Lactobacillus added to diets on fat deposition and meat quality of Sunit lambs

Y Zhang, M Zhang, L Su, L Zhao, L Sun, Y Jin, Y Guo - Meat Science, 2024 - Elsevier
In this study, we examined the impact of adding Lactobacillus to the diet on fat distribution
and meat quality of Sunit lambs. For 90 days, twenty-four lambs (19.31±0.47 kg) were fed …

A study on the treatment effects of Crataegus pinnatifida polysaccharide on non-alcoholic fatty liver in mice by modulating gut microbiota

P Hao, X Yang, W Yin, X Wang, Y Ling… - Frontiers in Veterinary …, 2024 - frontiersin.org
The objective of this study was to investigate the protective effect of Crataegus pinnatifida
polysaccharide (CPP) on non-alcoholic fatty liver disease (NAFLD) induced by a high-fat …